Corlieve Therapeutics SAS
Industry
- Pharmaceuticals
- Biotechnology
- Gene Therapy, Cell Therapy
See more in Biomedtracker
Latest on Corlieve Therapeutics SAS
Scrip
• By Mandy Jackson
PureTech Health plc, after the multibillion-dollar success of its last neuropsychiatry venture Karuna Therapeutics Inc., launched Seaport Therapeutics in April with $100m in series A funding and on 21
Scrip
• By Andrew McConaghie
UniQure is to cut its workforce by 28% and drop more than half its research and technology projects in an effort to streamline and focus its gene therapy-based business. The Amsterdam, Netherlands-he
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Roche Exits Gene Therapy Delivery Pact